INDOCO REMEDIES LIMITED : USFDA INSPECTION OBSERVATIONS

• The United States Food and Drug Administration (USFDA) inspected the company's manufacturing facility at Plant II (Sterile) located at Goa. • The inspection was conducted from August 27, 2026, to September 4, 2026. • Upon conclusion of the inspection, the company received seven (7) observations in Form 483. • Indoco Remedies Limited is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe.

Indoco Remedies Limited

Open attachment

← Back to feed